Waystar Holding Corp. (NASDAQ:WAY) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts.
On April 29, 2026, Waystar Holding Corp. reported Q1 adjusted EPS of $0.42, ahead of consensus estimates of $0.39, while revenue came in at $313.9 million versus expectations of $311.68 million. CEO Matt Hawkins said the company delivered a solid start to the year, supported by strong execution and continued platform expansion. He noted progress on the Iodine integration, the launch of new offerings including an AI-powered recoupment solution, and bookings that exceeded internal expectations as more healthcare providers standardize on Waystar’s platform.
Waystar reaffirmed its fiscal 2026 outlook, guiding for adjusted EPS of $1.59 to $1.68 compared with consensus estimates of $1.63, and revenue of $1.274 billion to $1.294 billion versus expectations of $1.29 billion.
Photo by George Morina on Pexels
Following the report, UBS analyst Kevin Caliendo lowered his price target on Waystar Holding Corp. to $37 from $41 while maintaining a Buy rating. The firm said the company posted solid results, with both total and subscription revenue exceeding expectations and EBITDA margins coming in above prior levels and long-term targets, signaling strong underlying profitability. However, UBS noted that unchanged full-year guidance and a slightly softer near-term growth cadence could weigh on sentiment, especially given the company’s history of raising expectations throughout the year.
Waystar Holding Corp. provides cloud-based software solutions that help healthcare providers manage payments, claims, and revenue cycle operations.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.